The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chorionic Gonadotropin for Injection Market Research Report 2025
Synopsis
Chorionic Gonadotropin for Injection is a medication that contains HCG and is used in fertility treatments and hormonal therapies.
The global Chorionic Gonadotropin for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chorionic Gonadotropin for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chorionic Gonadotropin for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chorionic Gonadotropin for Injection include Shanghai Livzon Pharmaceutical Co., Ltd., Qingdao Guanlong Biopharmaceutical Co., Ltd., Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd. and Merck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chorionic Gonadotropin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chorionic Gonadotropin for Injection.
Report Scope
The Chorionic Gonadotropin for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chorionic Gonadotropin for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chorionic Gonadotropin for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shanghai Livzon Pharmaceutical Co., Ltd.
Qingdao Guanlong Biopharmaceutical Co., Ltd.
Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Merck
Segment by Type
u-hCG
r-hCG
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chorionic Gonadotropin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chorionic Gonadotropin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Chorionic Gonadotropin for Injection is a medication that contains HCG and is used in fertility treatments and hormonal therapies.
The global Chorionic Gonadotropin for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chorionic Gonadotropin for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chorionic Gonadotropin for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chorionic Gonadotropin for Injection include Shanghai Livzon Pharmaceutical Co., Ltd., Qingdao Guanlong Biopharmaceutical Co., Ltd., Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd. and Merck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chorionic Gonadotropin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chorionic Gonadotropin for Injection.
Report Scope
The Chorionic Gonadotropin for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chorionic Gonadotropin for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chorionic Gonadotropin for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shanghai Livzon Pharmaceutical Co., Ltd.
Qingdao Guanlong Biopharmaceutical Co., Ltd.
Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Merck
Segment by Type
u-hCG
r-hCG
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chorionic Gonadotropin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chorionic Gonadotropin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Chorionic Gonadotropin for Injection Market Overview
1.1 Product Overview and Scope of Chorionic Gonadotropin for Injection
1.2 Chorionic Gonadotropin for Injection Segment by Type
1.2.1 Global Chorionic Gonadotropin for Injection Market Value Comparison by Type (2024-2030)
1.2.2 u-hCG
1.2.3 r-hCG
1.3 Chorionic Gonadotropin for Injection Segment by Application
1.3.1 Global Chorionic Gonadotropin for Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Chorionic Gonadotropin for Injection Market Size Estimates and Forecasts
1.4.1 Global Chorionic Gonadotropin for Injection Revenue 2019-2030
1.4.2 Global Chorionic Gonadotropin for Injection Sales 2019-2030
1.4.3 Global Chorionic Gonadotropin for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chorionic Gonadotropin for Injection Market Competition by Manufacturers
2.1 Global Chorionic Gonadotropin for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chorionic Gonadotropin for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chorionic Gonadotropin for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Chorionic Gonadotropin for Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chorionic Gonadotropin for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chorionic Gonadotropin for Injection, Product Type & Application
2.7 Chorionic Gonadotropin for Injection Market Competitive Situation and Trends
2.7.1 Chorionic Gonadotropin for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chorionic Gonadotropin for Injection Players Market Share by Revenue
2.7.3 Global Chorionic Gonadotropin for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chorionic Gonadotropin for Injection Retrospective Market Scenario by Region
3.1 Global Chorionic Gonadotropin for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chorionic Gonadotropin for Injection Global Chorionic Gonadotropin for Injection Sales by Region: 2019-2030
3.2.1 Global Chorionic Gonadotropin for Injection Sales by Region: 2019-2024
3.2.2 Global Chorionic Gonadotropin for Injection Sales by Region: 2025-2030
3.3 Global Chorionic Gonadotropin for Injection Global Chorionic Gonadotropin for Injection Revenue by Region: 2019-2030
3.3.1 Global Chorionic Gonadotropin for Injection Revenue by Region: 2019-2024
3.3.2 Global Chorionic Gonadotropin for Injection Revenue by Region: 2025-2030
3.4 North America Chorionic Gonadotropin for Injection Market Facts & Figures by Country
3.4.1 North America Chorionic Gonadotropin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chorionic Gonadotropin for Injection Sales by Country (2019-2030)
3.4.3 North America Chorionic Gonadotropin for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chorionic Gonadotropin for Injection Market Facts & Figures by Country
3.5.1 Europe Chorionic Gonadotropin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chorionic Gonadotropin for Injection Sales by Country (2019-2030)
3.5.3 Europe Chorionic Gonadotropin for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chorionic Gonadotropin for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Chorionic Gonadotropin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chorionic Gonadotropin for Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Chorionic Gonadotropin for Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Chorionic Gonadotropin for Injection Market Facts & Figures by Country
3.7.1 Latin America Chorionic Gonadotropin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chorionic Gonadotropin for Injection Sales by Country (2019-2030)
3.7.3 Latin America Chorionic Gonadotropin for Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chorionic Gonadotropin for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Chorionic Gonadotropin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chorionic Gonadotropin for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chorionic Gonadotropin for Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chorionic Gonadotropin for Injection Sales by Type (2019-2030)
4.1.1 Global Chorionic Gonadotropin for Injection Sales by Type (2019-2024)
4.1.2 Global Chorionic Gonadotropin for Injection Sales by Type (2025-2030)
4.1.3 Global Chorionic Gonadotropin for Injection Sales Market Share by Type (2019-2030)
4.2 Global Chorionic Gonadotropin for Injection Revenue by Type (2019-2030)
4.2.1 Global Chorionic Gonadotropin for Injection Revenue by Type (2019-2024)
4.2.2 Global Chorionic Gonadotropin for Injection Revenue by Type (2025-2030)
4.2.3 Global Chorionic Gonadotropin for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Chorionic Gonadotropin for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chorionic Gonadotropin for Injection Sales by Application (2019-2030)
5.1.1 Global Chorionic Gonadotropin for Injection Sales by Application (2019-2024)
5.1.2 Global Chorionic Gonadotropin for Injection Sales by Application (2025-2030)
5.1.3 Global Chorionic Gonadotropin for Injection Sales Market Share by Application (2019-2030)
5.2 Global Chorionic Gonadotropin for Injection Revenue by Application (2019-2030)
5.2.1 Global Chorionic Gonadotropin for Injection Revenue by Application (2019-2024)
5.2.2 Global Chorionic Gonadotropin for Injection Revenue by Application (2025-2030)
5.2.3 Global Chorionic Gonadotropin for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Chorionic Gonadotropin for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shanghai Livzon Pharmaceutical Co., Ltd.
6.1.1 Shanghai Livzon Pharmaceutical Co., Ltd. Corporation Information
6.1.2 Shanghai Livzon Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolio
6.1.5 Shanghai Livzon Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Qingdao Guanlong Biopharmaceutical Co., Ltd.
6.2.1 Qingdao Guanlong Biopharmaceutical Co., Ltd. Corporation Information
6.2.2 Qingdao Guanlong Biopharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolio
6.2.5 Qingdao Guanlong Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
6.3.1 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Corporation Information
6.3.2 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Description and Business Overview
6.3.3 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolio
6.3.5 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Recent Developments/Updates
6.4 Ningbo Renjian Pharmaceutical Group Co., Ltd.
6.4.1 Ningbo Renjian Pharmaceutical Group Co., Ltd. Corporation Information
6.4.2 Ningbo Renjian Pharmaceutical Group Co., Ltd. Description and Business Overview
6.4.3 Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolio
6.4.5 Ningbo Renjian Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Chorionic Gonadotropin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck Chorionic Gonadotropin for Injection Product Portfolio
6.5.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chorionic Gonadotropin for Injection Industry Chain Analysis
7.2 Chorionic Gonadotropin for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chorionic Gonadotropin for Injection Production Mode & Process
7.4 Chorionic Gonadotropin for Injection Sales and Marketing
7.4.1 Chorionic Gonadotropin for Injection Sales Channels
7.4.2 Chorionic Gonadotropin for Injection Distributors
7.5 Chorionic Gonadotropin for Injection Customers
8 Chorionic Gonadotropin for Injection Market Dynamics
8.1 Chorionic Gonadotropin for Injection Industry Trends
8.2 Chorionic Gonadotropin for Injection Market Drivers
8.3 Chorionic Gonadotropin for Injection Market Challenges
8.4 Chorionic Gonadotropin for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Chorionic Gonadotropin for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Chorionic Gonadotropin for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Chorionic Gonadotropin for Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Chorionic Gonadotropin for Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Chorionic Gonadotropin for Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Chorionic Gonadotropin for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Chorionic Gonadotropin for Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Chorionic Gonadotropin for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Chorionic Gonadotropin for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Chorionic Gonadotropin for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chorionic Gonadotropin for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Chorionic Gonadotropin for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chorionic Gonadotropin for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chorionic Gonadotropin for Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chorionic Gonadotropin for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Chorionic Gonadotropin for Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Chorionic Gonadotropin for Injection Sales Market Share by Region (2019-2024)
Table 19. Global Chorionic Gonadotropin for Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Chorionic Gonadotropin for Injection Sales Market Share by Region (2025-2030)
Table 21. Global Chorionic Gonadotropin for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Chorionic Gonadotropin for Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Chorionic Gonadotropin for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Chorionic Gonadotropin for Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Chorionic Gonadotropin for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Chorionic Gonadotropin for Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Chorionic Gonadotropin for Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Chorionic Gonadotropin for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Chorionic Gonadotropin for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Chorionic Gonadotropin for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Chorionic Gonadotropin for Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Chorionic Gonadotropin for Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Chorionic Gonadotropin for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Chorionic Gonadotropin for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Chorionic Gonadotropin for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Chorionic Gonadotropin for Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Chorionic Gonadotropin for Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Chorionic Gonadotropin for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Chorionic Gonadotropin for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Chorionic Gonadotropin for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Chorionic Gonadotropin for Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Chorionic Gonadotropin for Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Chorionic Gonadotropin for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Chorionic Gonadotropin for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Chorionic Gonadotropin for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Chorionic Gonadotropin for Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Chorionic Gonadotropin for Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Chorionic Gonadotropin for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Chorionic Gonadotropin for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Chorionic Gonadotropin for Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Chorionic Gonadotropin for Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Chorionic Gonadotropin for Injection Sales Market Share by Type (2019-2024)
Table 53. Global Chorionic Gonadotropin for Injection Sales Market Share by Type (2025-2030)
Table 54. Global Chorionic Gonadotropin for Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Chorionic Gonadotropin for Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Chorionic Gonadotropin for Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Chorionic Gonadotropin for Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Chorionic Gonadotropin for Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Chorionic Gonadotropin for Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Chorionic Gonadotropin for Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Chorionic Gonadotropin for Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Chorionic Gonadotropin for Injection Sales Market Share by Application (2019-2024)
Table 63. Global Chorionic Gonadotropin for Injection Sales Market Share by Application (2025-2030)
Table 64. Global Chorionic Gonadotropin for Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Chorionic Gonadotropin for Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Chorionic Gonadotropin for Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Chorionic Gonadotropin for Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Chorionic Gonadotropin for Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Chorionic Gonadotropin for Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Shanghai Livzon Pharmaceutical Co., Ltd. Corporation Information
Table 71. Shanghai Livzon Pharmaceutical Co., Ltd. Description and Business Overview
Table 72. Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product
Table 74. Shanghai Livzon Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 75. Qingdao Guanlong Biopharmaceutical Co., Ltd. Corporation Information
Table 76. Qingdao Guanlong Biopharmaceutical Co., Ltd. Description and Business Overview
Table 77. Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product
Table 79. Qingdao Guanlong Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Corporation Information
Table 81. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Description and Business Overview
Table 82. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Product
Table 84. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Recent Developments/Updates
Table 85. Ningbo Renjian Pharmaceutical Group Co., Ltd. Corporation Information
Table 86. Ningbo Renjian Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 87. Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Product
Table 89. Ningbo Renjian Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Chorionic Gonadotropin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Merck Chorionic Gonadotropin for Injection Product
Table 94. Merck Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Chorionic Gonadotropin for Injection Distributors List
Table 98. Chorionic Gonadotropin for Injection Customers List
Table 99. Chorionic Gonadotropin for Injection Market Trends
Table 100. Chorionic Gonadotropin for Injection Market Drivers
Table 101. Chorionic Gonadotropin for Injection Market Challenges
Table 102. Chorionic Gonadotropin for Injection Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chorionic Gonadotropin for Injection
Figure 2. Global Chorionic Gonadotropin for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Chorionic Gonadotropin for Injection Market Share by Type in 2023 & 2030
Figure 4. u-hCG Product Picture
Figure 5. r-hCG Product Picture
Figure 6. Global Chorionic Gonadotropin for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Chorionic Gonadotropin for Injection Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Chorionic Gonadotropin for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Chorionic Gonadotropin for Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Chorionic Gonadotropin for Injection Sales (2019-2030) & (K Units)
Figure 14. Global Chorionic Gonadotropin for Injection Average Price (US$/Unit) & (2019-2030)
Figure 15. Chorionic Gonadotropin for Injection Report Years Considered
Figure 16. Chorionic Gonadotropin for Injection Sales Share by Manufacturers in 2023
Figure 17. Global Chorionic Gonadotropin for Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Chorionic Gonadotropin for Injection Players: Market Share by Revenue in 2023
Figure 19. Chorionic Gonadotropin for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Chorionic Gonadotropin for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Chorionic Gonadotropin for Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Chorionic Gonadotropin for Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Chorionic Gonadotropin for Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Chorionic Gonadotropin for Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Chorionic Gonadotropin for Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Chorionic Gonadotropin for Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Chorionic Gonadotropin for Injection Sales Market Share by Country (2019-2030)
Figure 44. Latin America Chorionic Gonadotropin for Injection Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Chorionic Gonadotropin for Injection Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Chorionic Gonadotropin for Injection Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Chorionic Gonadotropin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Chorionic Gonadotropin for Injection by Type (2019-2030)
Figure 54. Global Revenue Market Share of Chorionic Gonadotropin for Injection by Type (2019-2030)
Figure 55. Global Chorionic Gonadotropin for Injection Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Chorionic Gonadotropin for Injection by Application (2019-2030)
Figure 57. Global Revenue Market Share of Chorionic Gonadotropin for Injection by Application (2019-2030)
Figure 58. Global Chorionic Gonadotropin for Injection Price (US$/Unit) by Application (2019-2030)
Figure 59. Chorionic Gonadotropin for Injection Value Chain
Figure 60. Chorionic Gonadotropin for Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
